Alpha DNA Investment Management’s Taylor Morrison TMHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,286
Closed -$446K 164
2024
Q4
$446K Buy
7,286
+455
+7% +$31.1K 0.17% 133
2024
Q3
$480K Buy
6,831
+797
+13% +$51.1K 0.18% 119
2024
Q2
$335K Sell
6,034
-4,320
-42% -$247K 0.13% 185
2024
Q1
$644K Buy
+10,354
New +$570K 0.24% 90
2021
Q2
Sell
-35
Closed -$1K 602
2021
Q1
$1K Hold
35
﹤0.01% 656
2020
Q4
$0 Buy
+35
New +$892 ﹤0.01% 629

Other funds holding TMHC

Alpha DNA Investment Management's TMHC Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Taylor Morrison (TMHC) in Q1 2025, closing a stake of 7,286 shares — an estimated $446K sold.

Alpha DNA Investment Management first reported a position in TMHC in Q4 2020 and held it in 6 quarters. The position peaked at $644K in Q1 2024. 442 funds tracked by Wall St. Rank hold TMHC as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Taylor Morrison position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,286 Taylor Morrison shares in Q1 2025, an estimated $446K.
  • Alpha DNA Investment Management first reported a position in Taylor Morrison in Q4 2020 and held it in 6 quarters.
  • Alpha DNA Investment Management's Taylor Morrison position peaked at $644K in Q1 2024.
  • 442 funds tracked by Wall St. Rank held Taylor Morrison as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.